Renal Cell Carcinoma

>

Latest News

George Discusses Potency of VEGF TKIs in Advanced Renal Cell Carcinoma
George Discusses Potency of VEGF TKIs in Advanced Renal Cell Carcinoma

March 22nd 2024

During a Case-Based Roundtable® event, Saby George, MD, discussed the case of a patient with clear cell renal cell carcinoma who progressed after left nephrectomy followed by treatment with axitinib plus pembrolizumab at recurrence.

Unique Challenges of Using IO/TKI Combinations in Metastatic RCC
Unique Challenges of Using IO/TKI Combinations in Metastatic RCC

March 12th 2024

Evolving Evidence Guides Treatment Selection for Favorable-Risk mRCC
Evolving Evidence Guides Treatment Selection for Favorable-Risk mRCC

March 6th 2024

Microbiome Impact and Promising Clinical Outcomes for Renal Cell Carcinoma
Microbiome Impact and Promising Clinical Outcomes for Renal Cell Carcinoma

March 3rd 2024

Guideline Recommendation Favors Doublet Over Triplet Therapy in ccRCC
Guideline Recommendation Favors Doublet Over Triplet Therapy in ccRCC

February 28th 2024

More News